CINDEFI   05381
CENTRO DE INVESTIGACION Y DESARROLLO EN FERMENTACIONES INDUSTRIALES
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Characterization of Bordetella pertussis clinical isolates biofilms by FT-IR spectroscopy
Autor/es:
CATTELAN, N; ARNAL, L; BOSCH, A; YANTORNO, OM
Lugar:
Berlín
Reunión:
Workshop; FT-IR Spectroscopy in Microbiological and Medical Diagnostics; 2013
Institución organizadora:
Robert Koch-Institute
Resumen:
Whooping cough is a highly contagious infectious disease of the upper respiratory tract caused by the Gram-negative pathogen Bordetella pertussis [1]. Despite widespread and efficient vaccination, in the last two decades there has been a worldwide resurgence of pertussis [2, 3]. The resurgence of the disease has been associated to various factors including suboptimal vaccines, waning immunity and pathogen adaptation to persist in vaccinated populations. Although traditionally known as a severe childhood disease recently, an increased incidence in adolescents and adults was reported. In the later groups the disease symptoms are mild or even not manifested, consequently, the infected individuals become silent carriers of the pathogen, facilitating its circulation in the population [4]. One proposed hypothesis to explain the survival and continued persistence of B. pertussis in human host is that this organism may adopt a biofilm lifestyle during respiratory infection as a strategy to survive and persist in their host [5]. The aim of this study was to get insights into the phenotypic diversity of B. pertussis local clinical isolates and a reference strain (B.p. Tohama I). Furthermore, we analyzed the ability of circulating isolates to grow as biofilm and compared their chemical composition with B. pertussis Tohama I strain biofilm by FT-IR spectroscopy. We studied the reference strain B. pertussis Tohama I and a total of 15 clinical isolates recovered in the period 2001-2008 from pediatric patients in Argentina. Firstly, we analyzed the phenotypic diversity of the isolates after 48 h of culturing on Bordet-Gengou agar at 36 ºC by FT-IR spectroscopy. No significant differences were observed among the general features of first derivative spectra belonging to the clinical isolates and the reference strain along the whole spectral range. The maximum spectral variance among 3 independent replicates of the same isolates (Dmax = 23  5) was similar to the spectral distance among different strains. Thus, all the clinical isolates studied and the Tohama I strain seemed to be phenotypically indistinguishable by FT-IR spectroscopy. Nevertheless, when the biofilm formation ability of these bacteria was assessed on 6-well-microtiter dishes after 72 h of growth by quantifying the sessile biomass with crystal violet [6], all clinical isolates showed a significantly greater capacity to form biofilms, compared to the reference strain. Besides, the biofilms produced on the wells for all the strains was scarped from the microtiter walls and collected with distilled water for FT-IR spectroscopy analysis. A semi-quantitative FT-IR analysis of the bands assigned to proteins (Amide II) and carbohydrates showed a relative increase in carbohydrate content for the biofilms of clinical isolates, probable due to a higher contribution of this component in the matrix of their mature biofilms. This is in accordance with proteomics results showing the increased expression of genes associated with energy metabolism. Overall, our results suggest a higher capability of clinical isolates than the reference strain to adopt the biofilm lifestyle, reinforcing the hypothesis that biofilm lifestyle can be considered as an ?evolution trait? adopted by B. pertussis to persist in their host.